Navigation Links
Studies of Alzheimer's Caregivers May Overlook Non-Spouses
Date:12/26/2012

WEDNESDAY, Dec. 26 (HealthDay News) -- Patients without spouses are underrepresented in Alzheimer's disease clinical trials and this imbalance could affect the findings of the trials, according to a new study.

Researchers looked at which type of caregiver Alzheimer's patients had in six clinical trials conducted by the Alzheimer's Disease Cooperative Study. The caregivers were categorized as either spouse, adult child or "other," according to the study, which was published in the Dec. 19 online issue of the journal Neurology.

"Nationwide, half of all unpaid Alzheimer's disease caregivers are under the age of 50 and as many as 68 percent are the children, children-in-law or grandchildren of these patients," study author Joshua Grill, assistant professor of neurology at the Mary S. Easton Center for Alzheimer's Disease Research at the University of California, Los Angeles, said in a journal news release.

"In contrast, in our analyses, 67 percent of the ... Alzheimer's clinical trial participants had a spouse as their [caregiver]," he said. "We found that there were several differences between people with spouse and adult child [caregivers] that could affect the results of the trials and interpretations of those results."

The type of caregiver appears to affect the risk of a patient dropping out of a clinical trial. Grill found that the risk of dropout among patients with a caregiver classified as "other" was 70 percent higher than for patients whose caregiver was their spouse.

The study also found that factors such as race and caregiver attitude also may affect patient recruitment to trials. Only 5 percent of patients in the trials were Hispanic, for example, and those with an adult-child caregiver were twice as likely as those with spouse partners to be Hispanic.

Only 6 percent of participants were black and patients with adult-child caregivers were nearly three times as likely to be black as those with spouse caregivers.

More information

The U.S. National Institute on Aging has more about participating in Alzheimer's disease clinical trials and studies.

-- Robert Preidt

SOURCE: Neurology, news release, Dec. 19, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Studies challenge standards to improve treatment outcomes for patients with clotting disorders
2. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
3. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
4. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
5. Sharp spike in computer-related injuries predicted for medical workers, find studies
6. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
7. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
8. New studies show effects of mammography guideline changes
9. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
10. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
11. Cancer Drug Reduced Relapses in MS Patients: Studies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies of Alzheimer's Caregivers May Overlook Non-Spouses
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: